Abstract
To assess the hypothesis that nitric oxide is critical in the pathogenesis of cerebral malaria, we analysed genetic variation in the proximal promoter region of NOS2A, the gene encoding inducible nitric oxide synthase. Sequencing 72 Gambian chromosomes revealed 11 single nucleotide polymorphisms in 2.5 kB (θ=8.6×10-4). Genotyping 104 nuclear families identified six common haplotypes. A single haplotype, uniquely defined by the NOS2A-1659T allele, was associated with cerebral malaria by a transmission disequilibrium test of 334 affected children and their parents (P=0.02). An independent case-control study of 505 different children from the same population replicated the allelic association with cerebral malaria (odds ratio: 1.31, P=0.04). Taken together these data indicate a weak but significant association of the NOS2A locus with susceptibility to cerebral malaria. Despite high linkage disequilibrium across the region studied, this association would not have been detected without the initial construction of a dense marker set for haplotype tagging.
Similar content being viewed by others
References
Al-Yaman FM, Mokela D, Genton B., Rockett KA, Alpers MP, Clark IA (1996) Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 90:270–273
Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL (1996) Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184:557–567
Burgner D, Xu W, Rockett K, Gravenor M, Charles IG, Hill AV, Kwiatkowski D (1998) Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 352:1193–1194
Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Lane CR, Lim EP, Kalayanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231–238
Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengard J, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF (1998) Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet 63:595–612
Clark IA, Rockett KA (1996) Nitric oxide and parasitic disease. Adv Parasitol 37:1–56
Clark IA, Rockett KA, Cowden WB (1992) Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 340:894–896
Clark IA, Awburn MM, Whitten RO, Carr RA, Liomba NG, Molyneux ME, Taylor TE (1999) Immunohistochemical evidence for iNOS and nitrotyrosine production in fatal falciparum malaria in African children. Acta Physiol Scand 167 (Suppl 645):14
Clayton D (1999) A generalization of the transmission/disequilibrium test for uncertain haplotype transmission. Am J Hum Genet 65:1170–1177
Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES (2001) High-resolution haplotype structure in the human genome. Nat Genet 29:229–232
Gavrilyuk V, Horvath P, Weinberg G, Feinstein DL (2001) A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J Neurochem 78:129–140
Granger DL, Anstey NM, Miller WC, Weinberg JB (1999) Measuring nitric oxide production in human clinical studies. Methods Enzymol 301:49–61
Hensbroek MB van, Palmer A, Jaffar S, Schneider G, Kwiatkowski D (1997) Residual neurologic sequelae after childhood cerebral malaria. J Pediatr 131:125–129
Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature 352:595–600
Hoffman SL, Franke ED, Hollingdale MR, Druilhe P (1996) Attacking the infected hepatocyte. In: Hoffman SL (ed) Malaria vaccine development: a multi-immune response approach. American Society for Microbiology, Washington DC, pp 2005–2006
Hull J, Ackerman H, Isles K, Usen S, Pinder M, Thomson A, Kwiatkowski D (2001) Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 69:413–419
Ikuta S, Takagi K, Wallace RB, Itakura K (1987) Dissociation kinetics of 19 base paired oligonucleotide-DNA duplexes containing different single mismatched base pairs. Nucleic Acids Res 15:797–811
Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA (2001) Haplotype tagging for the identification of common disease genes. Nat Genet 29:233–237
Kremsner PG, Winkler S, Wildling E, Prada J, Bienzle U, Graninger W, Nussler AK (1996) High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 90:44–47
Kruglyak L (1999) Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139–144
Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351:265–266
Kun JF, Klabunde J, Lell B, Luckner D, Alpers M, May J, Meyer C, Kremsner PG (1999) Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. Am J Trop Med Hyg 61:776–779
Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG (2001) Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184:330–336
Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB (1999) Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with Malaria. J Infect Dis 180:1994–2002
Linn SC, Morelli PJ, Edry I, Cottongim SE, Szabo C, Salzman AL (1997) Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am J Physiol 272:G1499–G1508
Marks-Konczalik J, Chu SC, Moss J (1998) Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem 273:22201–22208
Molyneux M, Taylor T, Wirima J, Borgstein A (1989) Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71:441–459
Morris BJ, Markus A, Glenn CL, Adams DJ, Colagiuri S, Wang L (2002) Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J Mol Med 80:96–104
Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417–2423
Pance A, Chantome A, Reveneau S, Bentrari F, Jeannin JF (2002) A repressor in the proximal human inducible nitric oxide synthase promoter modulates transcriptional activation. FASEB J 16:631–633
Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678–680
Rockett KA, Awburn MM, Cowden WB, Clark IA (1991) Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 59:3280–3283
Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D (1998) 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 66:5314–5321
Schaid DJ (1996) General score tests for associations of genetic markers with disease using cases and their parents. Genet Epidemiol 13:423–449
Schoedon G, Schneemann M, Walter R, Blau N, Hofer S, Schaffner A (1995) Nitric oxide and infection: another view. Clin Infect Dis 21 (Suppl 2):S152–S157
Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506–516
Spitsin SV, Koprowski H, Michaels FH (1996) Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter. Mol Med 2:226–235
Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D (2000) Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 20:9113–9119
Vera ME de, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM Jr, Billiar TR, Geller DA (1996) Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 93:1054–1059
Wallace RB, Shaffer J, Murphy RF, Bonner J, Hirose T, Itakura K (1979) Hybridization of synthetic oligodeoxyribonucleotides to phi chi 174 DNA: the effect of single base pair mismatch. Nucleic Acids Res 6:3543–3557
Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Pruss M, Reuter I, Schacherer F (2000) TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 28:316–319
Xu W, Liu L, Emson PC, Harrington CR, Charles IG (1997) Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene 204:165–170
Acknowledgements
We thank the patients and their families, and our colleagues at the Royal Victoria Hospital, Banjul, for their kind cooperation during this study. We are very grateful to Fatoumatta Sisay-Joof for help with DNA extraction and sample organization. This study was funded by the Medical Research Council.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s00439-003-1068-4.
Rights and permissions
About this article
Cite this article
Burgner, D., Usen, S., Rockett, K. et al. Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Hum Genet 112, 379–386 (2003). https://doi.org/10.1007/s00439-002-0882-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-002-0882-4